NIH-funded research R01 grant

Psychosis in Diverse Settings: Understanding Global Differences in Treatment and Genomics

Official title: Psychosis in Ancestrally Diverse Settings (PADS)

Funded at Suny Downstate Medical Center · NIH-11392945 · Data updated 2026-11-12

Aims to understand how psychotic disorders differ in people from diverse global backgrounds and how genetic factors relate to treatment outcomes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSuny Downstate Medical Center
NIH-funded
Lab location1 site (Brooklyn, United States)
Project startAugust 7, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$230,096
NIH project number5R01MH137768-03
Project IDNIH-11392945 on NIH RePORTER

Who could benefit from this research

Could help

Adults with psychotic disorders across participating sites in the Global South and the US.

Less likely to help

Patients not enrolled in the inpatient cohorts or without psychotic disorders may not directly benefit.

What this research studies

This grant brings together researchers from New York, Nigeria, and the Caribbean to study how psychotic disorders present and respond to treatment in global south settings. It will enroll patients receiving inpatient care and use state-of-the-art genome sequencing to explore genetic factors linked to psychosis. The team will compare these populations with US studies to see if current genetic risk scores apply across diverse groups. Findings could highlight new approaches to care that consider ancestry and regional differences. The project builds on prior INTREPID work to deepen understanding of untreated psychosis and treatment responses in varied populations.

Why it matters

Potential benefit: If successful, patients from diverse backgrounds could receive more accurate diagnoses and personalized treatment approaches in the future.

How similar studies have gone: Prior INTREPID studies showed feasibility of cross-population comparisons and laid groundwork for genomic analyses in diverse groups.

Where this research is happening

  • Suny Downstate Medical Center
    Brooklyn, United States
    Active

Researchers

  • Principal investigator: Bigdeli, Tim Bernard — Suny Downstate Medical Center
  • Study coordinator: Bigdeli, Tim Bernard

Related research

Other NIH-funded projects on the same topics.

  • Psychosis in diverse settings across the world

    This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592428

  • Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South

    A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592427

  • A new online brain-scan-style tool to spot early psychosis risk

    A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.

    NIH research Northwestern University · Chicago, United States · NIH-11590585

  • Genetic clues for early-onset psychosis in Latino youth

    This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11554752

  • Biomarkers to tailor rehab for Veterans with schizophrenia

    A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.

    NIH research VA San Diego Healthcare System · San Diego, United States · NIH-11552825

  • Computational analysis of facial expression in early psychosis

    Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11539126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.